Delta peritoneal cancer index (ΔPCI): A new dynamic prognostic parameter for survival in patients with colorectal peritoneal metastases-Reference-Cited by-同舟云学术

Delta peritoneal cancer index (ΔPCI): A new dynamic prognostic parameter for survival in patients with colorectal peritoneal metastases

Published:2020-04 Issue:4 Volume:46 Page:590-599
ISSN:0748-7983
Container-title:European Journal of Surgical Oncology
language:en
Short-container-title:European Journal of Surgical Oncology

Author:

Hentzen Judith E.K.R.,van der Plas Willemijn Y.,Kuipers Hendrien,Ramcharan Swades,Been Lukas B.,Hoogwater Frederik J.H.,van Ginkel Robert J.,van Dam Gooitzen M.,Hemmer Patrick H.J.,Kruijff Schelto

Publisher

Elsevier BV

Subject

Oncology,General Medicine,Surgery

Reference50 articles.

1. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBAN 2012;Ferlay;Int J Cancer,2015

2. Challenging the dogma of colorectal peritoneal metastases as an untreatable condition: results of a population-based study;Razenberg;Eur J Cancer,2016

3. Bevacizumab in addition to palliative chemotherapy in patients with peritoneal carcinomatosis of colorectal origin: a nationwide population-based study;Razenberg;Clin Colorectal Cancer,2016

4. Evaluation of best supportive care and systemic chemotherapy as treatment stratified according to the retrospective peritoneal surface disease severity score (PSDSS) for peritoneal carcinomatosis of colorectal origin;Pelz;BMC Canc,2010

5. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal metastases from colorectal origin;Kok;Br J Surg,2017

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic Value of Peritoneal Cancer Index After Complete Cytoreductive Surgery in Advanced Ovarian Cancer;Anticancer Research;2022-04-30

2. Determination of whether HIPEC is beneficial in patients with synchronous peritoneal and liver metastases from colorectal cancer (Review);Experimental and Therapeutic Medicine;2021-09-07

3. Treatment of advanced-stage ovarian cancer including combination of intra-abdominal chemotherapy;Ural Medical Journal;2021-07-19

4. Effective Strategies to Predict Survival of Colorectal Peritoneal Metastases Patients Eligible for Cytoreductive Surgery and HIPEC;Cancer Management and Research;2021-07